Synchronous primary corpus and ovarian cancer: High incidence of endometriosis and thrombosis

Por YAMANOI, KOJI, MANDAI, MASAKI, SUZUKI, AYAKO, MATSUMURA, NORIOMI, BABA, TSUKASA, YOSHIOKA, YUMIKO, KOSAKA, KENZO, KONISHI, IKUO
Publicado em 2012

Combination of Aprepitant, Azasetron, and Dexamethasone as Antiemetic Prophylaxis in Women with Gynecologic Cancers Receiving Paclitaxel/Carboplatin Therapy

Por Koshiyama, Masafumi, Matsumura, Noriomi, Imai, Saeko, Yamanoi, Koji, Abiko, Kaoru, Yoshioka, Yumiko, Yamaguchi, Ken, Hamanishi, Junzo, Baba, Tsukasa, Konishi, Ikuo
Publicado no Med Sci Monit (2017)

Suppression of ABHD2, identified through a functional genomics screen, causes anoikis resistance, chemoresistance and poor prognosis in ovarian cancer

Por Yamanoi, Koji, Matsumura, Noriomi, Murphy, Susan K., Baba, Tsukasa, Abiko, Kaoru, Hamanishi, Junzo, Yamaguchi, Ken, Koshiyama, Masafumi, Konishi, Ikuo, Mandai, Masaki
Publicado no Oncotarget (2016)

Clinical efficacy of neoadjuvant chemotherapy with irinotecan (CPT-11) and nedaplatin followed by radical hysterectomy for locally advanced cervical cancer

Por Abou-Taleb, Hisham A, Koshiyama, Masafumi, Matsumura, Noriomi, Baba, Tsukasa, Yamaguchi, Ken, Hamanishi, Junzo, Abiko, Kaoru, Yamanoi, Koji, Murakami, Ryusuke, Horikawa, Naoki, Taha, Ahmed AA, Kitamura, Sachiko, Konishi, Ikuo
Publicado no J Int Med Res (2016)